World News: 21:01 GMT Wednesday 15th May 2019. [Agios Pharmaceuticals, Inc. via Globe Newswire via SPi World News]
CAMBRIDGE Mass May 15 2019 GLOBE NEWSWIRE -- Agios Pharmaceuticals Inc NASDAQAGIO ain the field of cellular metabolism to treat cancer and rare diseases today announced that the Phase 3 ClarIDHy trial of TIBSOVO (ivosi...
Globe Newswire: 21:01 GMT Wednesday 15th May 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.